RxDoctor Payments Data

Peter Partee, MD

Family Medicine · Laurens, SCNPI 1912945841

Payments from drug & device makers

$17,752in general payments, 2019–2025

Across 513 payments — averaging $34.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dexcom, Inc.$10K
  • AbbVie$2K
  • Novo Nordisk$848
  • AstraZeneca$738
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$457
  • Lilly USA, LLC$449
  • plus $4K from 32 others

What the payments were for

  • Speaking & faculty fees$8,94350%
  • Travel & lodging$6294%
  • Food & beverage$8,18046%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,752 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$196,095
Medicare patients
370
Services billed
3,350

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin178$184,499
OzempicSemaglutide157$159,529
RybelsusSemaglutide64$94,032
EliquisApixaban108$85,654
MounjaroTirzepatide60$80,515
LinzessLinaclotide77$56,447
FarxigaDapagliflozin Propanediol70$48,141
TrulicityDulaglutide35$41,290
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$32,987
MyrbetriqMirabegron45$25,252
JanuviaSitagliptin Phosphate22$24,169
KerendiaFinerenone32$23,370
Tresiba Flextouch U-200Insulin Degludec16$22,899
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog17$17,394
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog24$17,039

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$848$253,561221 claims
Boehringer IngelheimJardiance, Synjardy, Stiolto Respimat$177$197,713204 claims
Lilly USA, LLCMounjaro, Trulicity$449$121,80495 claims
PfizerEliquis, Premarin$330$92,222122 claims
AstraZenecaFarxiga, Breztri Aerosphere, Bevespi Aerosphere$738$63,72599 claims
AbbVieLinzess$1,569$56,44777 claims
GSKTrelegy Ellipta, Breo Ellipta$413$41,32946 claims
MerckJanuvia, Janumet Xr$73$30,64534 claims
Astellas Pharma US IncMyrbetriq$119$25,25245 claims
BayerKerendia$157$23,37032 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$457$9,25017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Laurens

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →